WeVote
Log In

Bill

Bill

HD 2506

An Act to reduce the risks associated with allergic reactions

194th Legislature (2025-2026) Introduced by John Moran

Massachusetts bill requiring increased epinephrine access and staff training to prevent deaths from severe allergic reactions in public settings.

0
WeVote Research Nonpartisan
Bill Summary · HD 2506

Legislative bill overview

HD 2506 aims to reduce risks from allergic reactions through enhanced preparedness and response measures. The bill likely establishes requirements for epinephrine auto-injector availability, training protocols, or emergency action plans in schools and public facilities. Specific provisions would mandate increased accessibility to emergency medications and staff education on anaphylaxis recognition and treatment.

Why is this important

Anaphylaxis is a life-threatening allergic reaction that can develop rapidly, and delayed treatment significantly increases mortality risk. Ensuring widespread access to epinephrine auto-injectors and trained responders in community settings can mean the difference between a managed emergency and a fatal outcome, particularly for children in schools where allergic incidents commonly occur.

Potential points of contention

  • Funding responsibility: Whether schools and public facilities must bear costs of stockpiling auto-injectors and training staff, or if state/federal funding supports implementation
  • Liability and liability protection: How entities are protected or held accountable if emergency protocols fail or medications are used improperly
  • Scope of coverage: Whether requirements apply only to schools or extend to all public buildings, private facilities, and workplaces, creating varying compliance burdens

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.